1. LncRNA MEG3: Potential stock for precision treatment of cardiovascular diseases
   Zining Li et al, 2022, Frontiers in Pharmacology CrossRef
2. The FOXO family of transcription factors: key molecular players in gastric cancer
   Ying Liu et al, 2022, Journal of Molecular Medicine CrossRef
3. Recent advancements in the molecular biology of pituitary adenomas
   Allison C. Zheng et al, 2022, Expert Review of Endocrinology & Metabolism CrossRef
4. Emerging Roles of miRNA, lncRNA, circRNA, and Their Cross-Talk in Pituitary Adenoma
   Wentao Wu et al, 2022, Cells CrossRef
5. Regulation of long noncoding RNAs in the pathogenesis and clinical implications of pituitary adenomas
   Ling Wang et al, 2023, Immunity, Inflammation and Disease CrossRef
6. Role of lncRNAs in brain tumors
   Ashkan Pouyan et al, 2024, Gene Reports CrossRef
7. Dihydroartemisinin Affects STAT3/DDA1 Signaling Pathway and Reverses Breast Cancer Resistance to Cisplatin
   Jing Zhang et al, 2023, The American Journal of Chinese Medicine CrossRef
8. The Emerging Role of Non-Coding RNAs in Pituitary Gland Tumors and Meningioma
   Soudeh Ghafouri-Fard et al, 2021, Cancers CrossRef
9. The Long Noncoding RNA MEG3 Retains Epithelial-Mesenchymal Transition by Sponging miR-146b-5p to Regulate SLFN5 Expression in Breast Cancer Cells
   Xuefeng Gu et al, 2022, Journal of Immunology Research CrossRef
10. LncRNA HLA-F-AS1 Enhances the Migration, Invasion and Apoptosis of Glioblastoma Cells by Targeting lncRNA MEG3
    Yanhua Wang et al, 2021, Cancer Management and Research CrossRef